Anticoagulation Strategies for Primary Percutaneous Coronary Intervention
Author:
Affiliation:
1. From the Department of Medicine and the Cardiovascular Research Institute, University of Vermont College of Medicine, Burlington.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Link
https://www.ahajournals.org/doi/pdf/10.1161/CIRCINTERVENTIONS.115.001947
Reference77 articles.
1. Increasing Percutaneous Coronary Interventions for ST-Segment Elevation Myocardial Infarction in the United States
2. Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective study
3. Impact of Time of Presentation on Process Performance and Outcomes in ST-Segment–Elevation Myocardial Infarction
4. Acute Stent Thrombosis After Primary Percutaneous Coronary Intervention
5. Comprehensive Meta-Analysis of Safety and Efficacy of Bivalirudin Versus Heparin With or Without Routine Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndrome
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Risk Burden of Cancer in Patients Treated With Abbreviated Dual Antiplatelet Therapy After PCI: Analysis of Multicenter Controlled High-Bleeding Risk Trials;Circulation: Cardiovascular Interventions;2024-04
2. A BRIGHT outlook for bivalirudin in patients with ST-segment elevation myocardial infarction;European Heart Journal;2022-12-07
3. Periprocedural antithrombotic treatment in complex percutaneous coronary intervention;Journal of Cardiovascular Pharmacology;2021-12-07
4. Bivalirudin Use for Primary Percutaneous Coronary Intervention on Long-Term Mortality;Journal of Cardiovascular Pharmacology;2021-07
5. Dual anti-platelet therapy following percutaneous coronary intervention in a population of patients with thrombocytopenia at baseline: a meta-analysis;BMC Pharmacology and Toxicology;2020-04-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3